You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in the Czech Republic

Mar 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Czech Republic with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Czech Republic, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Czech Republic for free:

The Consumer Health in Czech Republic market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Czech Republic?
  • What are the major brands in Czech Republic?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Consumer health records satisfactory growth

As a result of the financial crisis and declining disposable incomes, consumers reduced expenditure during 2009 and 2010. However, consumer health was one of the fast-moving consumer goods areas least affected by the downturn as such products are considered to be essential by the majority of consumers. As a result, consumer health was only affected marginally and recorded satisfactory growth in 2010. Nevertheless, growth in 2009 and 2010 was significantly hampered by the impact of the international credit crunch.

Wound care leads growth in 2010

Wound care was the fastest growing consumer health area in 2010, with sales being fuelled by rising demand for first aid kits as a result of a new decree issued by the Ministry of Transport that obliged all motor vehicles to have such kits by 1 January 2011. The decree also resulted in an increase in average first aid kit prices as it obliged manufacturers to include several new medical aids such as thermo-insulating foil, resuscitative masks, metal scissors with rounded edges, and leaflets that instruct how to provide first aid to an injured person in each kit. However, now that most consumers have stocked up on the new kits, retail value sales in this area will decline rapidly in 2011.

Zentiva and Walmark lead sales

Zentiva led consumer health sales in 2010 and was closely followed by domestic company Walmark. Zentiva (formerly Zentiva as and Leciva) was acquired by Sanofi-Aventis in 2009 via the purchasing of global brand owner Zentiva NV. Both companies are well-established in the Czech Republic and their brands are well accepted and known amongst Czech consumers. Moreover, both companies also offer a wide range of products at reasonable prices. While Zentiva led OTC products sales in 2010, Walmark was clear leader within vitamins and dietary supplements and also ranked first within sports nutrition in 2010. Both companies have production plants in the Czech Republic.

Chemists/pharmacies remains leading distribution channel

Although the retail value share of chemists/pharmacies decreased slightly in 2010, the channel continues to dominate consumer health distribution due to the fact that pharmacies are a traditional consumer health channel and offer a wide range of such products. Consumers also prefer pharmacies due to the fact that they can gain advice and recommendations from educated pharmacists in such outlets. Internet retailing recorded the largest increase in distribution value share in 2010. Online shopping continues to increase in popularity amongst Czech consumers due to greater convenience, lower pricing, and the fact that online pharmacies are gradually broadening their product ranges.

Consumer health set to record further growth

Consumer health forecast period constant retail value growth will be higher than that recorded during the review period, with sales being driven by rising interest in preventive and self medication, current lifestyle trends, and the worsening environment. All areas will record satisfactory growth with the exception of wound care (due to declining demand for first aid kits) and tonics and bottled nutritive drinks (due to declining popularity of such drinks).

Table of Contents

Table of Contents

Consumer Health in the Czech Republic - Industry Overview

EXECUTIVE SUMMARY

Consumer health records satisfactory growth

Wound care leads growth in 2010

Zentiva and Walmark lead sales

Chemists/pharmacies remains leading distribution channel

Consumer health set to record further growth

KEY TRENDS AND DEVELOPMENTS

Economic downturn has only marginal impact on consumer healthcare sales

First private label products introduced in the Czech Republic

Growing interest in self-medication boosting consumer healthcare sales

Increasing presence of multinationals

Chemists/pharmacies continue to lead distribution

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares by Value 2006-2010
  • Table 6 Consumer Health Brand Shares by Value 2007-2010
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC Healthcare Switches 2008-2010

DEFINITIONS

  • Summary 2 Research Sources

Consumer Health in the Czech Republic - Company Profiles

Green Swan Pharmaceuticals CR as - Consumer Health - Czech Republic

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 4 Green Swan Pharmaceuticals CR as: Competitive Position 2010

Profarma Produkt sro - Consumer Health - Czech Republic

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 6 Profarma Produkt sro: Competitive Position 2010

Vitar sro - Consumer Health - Czech Republic

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Vitar sro: Competitive Position 2010

Walmark as - Consumer Health - Czech Republic

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 10 Walmark as: Competitive Position 2010

Zentiva ks - Consumer Health - Czech Republic

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 12 Zentiva ks: Competitive Position 2010

Adult Mouth Care in the Czech Republic - Category Analysis

HEADLINES

TRENDS

  • Although adult mouth care recorded a healthy review period current retail value CAGR of 4%, sales increased by just 2% in 2010 due to the impact of the economic downturn on consumer disposable incomes.

SWITCHES

COMPETITIVE LANDSCAPE

  • Adult mouth care is dominated by two companies. GlaxoSmithKline led sales in 2010, recording a retail value share of 21%, and was very closely followed by domestic company Aura Medical which also recorded a retail value share of 21%.

PROSPECTS

  • Adult mouth care constant retail value sales are projected to increase by a total of 4% over the forecast period. However, the fact that sales will only reach CZK97 million by 2015 means that adult mouth care will remain a niche area. The projected forecast period constant retail value CAGR of 1% is in-line with the review period average as no significant changes are expected within the area over the coming years.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2005-2010
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 13 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 14 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in the Czech Republic - Category Analysis

HEADLINES

TRENDS

  • Analgesics was one of the best performing OTC areas in 2010 as it offers products that provide a quick and effective solution to pain. Analgesics are mostly used to relieve common pains such as headaches, period pain, muscle aches, and other conditions that do not require consultation with a doctor and are found within the vast majority of Czech homes. Sales of analgesics have also been boosted by the introduction of doctor visit and prescription fees in 2008, with many consumers now preferring to self-medicate.

SWITCHES

COMPETITIVE LANDSCAPE

  • Zentiva led analgesics sales in 2010, recording a retail value share of 20%. The company is strong within many areas thanks to its well-known and popular brands. Zentiva led sales within acetaminophen, ibuprofen, child-specific ibuprofen, and topical analgesics/anaesthetic and ranked second within child-specific acetaminophen in 2010. The company’s Ibalgin and Paralen brands are amongst the best known analgesics products in the Czech Republic and enjoy strong consumer loyalty and trust due to the fact that they have been available for many years.

PROSPECTS

  • Analgesics constant retail value sales are projected to increase by a total of 21% over the forecast period. Demand for analgesics will be supported by the increasingly hectic pace of modern life and also by the fact that the introduction of doctor and prescription fees is encouraging consumers to self-medicate. Moreover, analgesics will remain one of the most basic and essential items within the medicine cabinets of most Czech households. Analgesics constant retail value sales are projected to exceed CZK2.2 billion by 2015.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2005-2010
  • Table 18 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 19 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 20 Analgesics Company Shares by Value 2006-2010
  • Table 21 Analgesics Brand Shares by Value 2007-2010
  • Table 22 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 23 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in the Czech Republic - Category Analysis

HEADLINES

TRENDS

  • Calming and sleeping recorded a healthy review period current retail value CAGR of 3%. Consumption in this area is being fuelled by the fact that the increasingly hectic and stressful pace of modern life is resulting in an increase in the number of people suffering from sleeping disorders, depression, and anxiety.

SWITCHES

COMPETITIVE LANDSCAPE

  • Calming and sleeping is dominated by two multinational companies. Sandoz led sales in 2010, recording a retail value share of 28%, and was closely followed by Teva Czech Industries (formerly Ivax Pharmaceuticals) with a retail value share of 27%. The success of these companies can be attributed to the popularity of their respective Persen and Novo-Passit brands. These two products have calming effects and are primarily intended for the treatment of complaints such as aggravation, mental strain, anxiety, moodiness, or attention deficit disorders. Furthermore, these two products can also be used for the treatment of sleeping disorders.

PROSPECTS

  • Calming and sleeping constant retail value sales are projected to increase by a total of 6% over the forecast period. This projected growth is higher than that recorded over the review period due to rising demand as a result of the increasingly hectic and stressful pace of modern life in the Czech Republic. Moreover, OTC calming and sleeping products will continue to gain ground at the expense of prescription drugs which are perceived as being less healthy and safe.

CATEGORY DATA

  • Table 24 Sales of Adult Mouth Care: Value 2005-2010
  • Table 25 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 26 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 27 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 28 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 29 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in the Czech Republic - Category Analysis

HEADLINES

TRENDS

  • Cough, cold and allergy remedies posted satisfactory current retail value growth of 4% in 2010, with demand being boosted by the relatively long winter and exceptionally cold spring in 2010 and the consequent higher incidence of colds and flus. However, growth was hampered by rising consumer price sensitivity due to the economic downturn. As a result, growth in 2010 was lower than that recorded before the economic downturn.

SWITCHES

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline led cough, cold and allergy remedies sales in 2010, recording a retail value share of 12%. The company is strongest within combination products where it led sales in 2010 with a retail value share of 41%. The company became leader in this area in 2009 when consumers shifted away from re-classified products containing pseudoephedrine (Nurofen Stopgrip and Modofen) to alternatives such as GlaxoSmithKline’s Coldrex, Coldrex HotRem, and Coldrex Nite. GlaxoSmithKline is also present within cough remedies where it ranked fourth in 2010 and pharyngeal preparations where it ranked seventh.

PROSPECTS

  • Cough, cold and allergy remedies constant retail value sales are projected to increase by a total of 20% over the forecast period. Growth over the coming years will be higher than that recorded during the review period, with demand being fuelled by the increasingly hectic pace of modern life and worsening environmental conditions. Self-medication is the fastest and simplest solution for treating flus and colds. Moreover, the fact that a wide range of differently priced cough, cold and allergy remedies that come in a large number of formats are available also helps to attract consumers.

CATEGORY DATA

  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 32 Sales of Decongestants by Category: Value 2005-2010
  • Table 33 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 34 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 35 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 36 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 38 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in the Czech Republic - Category Analysis

HEADLINES

TRENDS

  • Digestive remedies recorded relatively stable growth over the review period, with constant retail value sales increasing at an average annual rate of 3%. The consumption of digestive remedies is being fuelled by the modern lifestyle and eating habits of Czech consumers as well as traditional Czech cuisine which is relatively heavy and typically consists of red meat, high calorie sauces, and heavy side dishes such as dumplings. Moreover, many Czechs do not follow balanced diets and are leading increasingly hectic lifestyles and working longer and irregular hours. For example, a growing number of people are eating on the go or within fast food outlets. Furthermore, many Czechs skip breakfast and drink large amounts of alcohol, especially beer.

SWITCHES

COMPETITIVE LANDSCAPE

  • Zentiva led sales within digestive remedies in 2010, recording a retail value share of 10%. Zentiva was bought by Sanofi-Aventis in 2009 and led sales within diarrhoeal remedies and ranked third within digestive enzymes and laxatives in 2010. Zentiva has been operating in the Czech Republic for many years and its brands enjoy strong consumer loyalty and trust. The company’s Endiaron diarrhoeal remedy brand has been available since before 1989 and led sales within digestive remedies in 2010 with a retail value share of 6%.

PROSPECTS

  • Although a growing number of consumers are aware of the importance of a balanced diet, many Czechs still have unhealthy eating habits. As a result, it is expected that diet-related illnesses will remain relatively common over the forecast period.

CATEGORY DATA

  • Table 40 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 41 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 42 Digestive Remedies Company Shares by Value 2006-2010
  • Table 43 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 44 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 45 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in the Czech Republic - Category Analysis

HEADLINES

TRENDS

  • Ear care remains a niche area, recording current retail value sales of just CZK14 million in 2010. Although ear care posted a relatively good review period current retail value CAGR of 4%, growth slowed towards the end of the review period as a result of the impact of the economic crisis on consumer disposable incomes, with sales increasing by just 2% in 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • Ear care is dominated by Laboratoires Diepharm, which recorded a retail value share of 65% in 2010, and Herb-Pharma (31%). Herb-Pharma registered a three percentage point increase in retail value share in 2010 at the expense of Laboratoires Diepharm due to the increasing popularity of its Aurecon brand thanks to its growing availability in a range of different formats.

PROSPECTS

  • Ear care constant retail value sales are projected to increase by a total of 6% over the forecast period to reach CZK15 million by 2015. Sales over the coming years will mainly be boosted by increasing consumer health awareness.

CATEGORY DATA

  • Table 46 Sales of Ear Care: Value 2005-2010
  • Table 47 Sales of Ear Care: % Value Growth 2005-2010
  • Table 48 Ear Care Company Shares by Value 2006-2010
  • Table 49 Ear Care Brand Shares by Value 2007-2010
  • Table 50 Forecast Sales of Ear Care: Value 2010-2015
  • Table 51 Forecast Sales of Ear Care: % Value Growth 2010-2015

Emergency Contraception in the Czech Republic - Category Analysis

TRENDS

  • Emergency contraception was only available via prescription in the Czech Republic in 2010 and there are no indications that these products will be made available without a prescription in the near future.

Eye Care in the Czech Republic - Category Analysis

HEADLINES

TRENDS

  • Demand for eye care products is being driven by current lifestyle trends and worsening environmental conditions. Czech consumers are spending longer and longer in front of computers and TV screens both at work and home. In addition, driving, smog, and dust are putting further stress on eyes. All these negative factors are causing eye irritation, dryness, redness, itching, and burning. Moreover, the number of people suffering from allergies is also increasing as a result of growing pollution.

SWITCHES

COMPETITIVE LANDSCAPE

  • Teva Czech Industries led eye care in 2010, recording a retail value share of 40%, and was closely followed by Zentiva (38%). Johnson & Johnson ranked third with a retail value share of 14%.

PROSPECTS

  • Eye care constant retail value sales are projected to increase by a total of 14% over the forecast period to reach CZK170 million by 2015. This projected increase is higher than that recorded over the review period as sales will be boosted by current consumer lifestyle trends and worsening environmental conditions.

CATEGORY DATA

  • Table 52 Sales of Eye Care by Category: Value 2005-2010
  • Table 53 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 54 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 55 Eye Care Company Shares by Value 2006-2010
  • Table 56 Eye Care Brand Shares by Value 2007-2010
  • Table 57 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 58 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in the Czech Republic - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional products recorded a healthy review period current retail value CAGR of 4%, with demand being fuelled by rising consumer health and wellness awareness and the increasing popularity of self-medication and preventative medication. Herbal products are perceived as being healthy and safe thanks to their natural origin and limited side effects. Moreover, interest in herbal products is also being fuelled by the large number of articles appearing in various magazines and newspapers that highlight the benefits of plants and medicinal herbs as well as recommendations from doctors and pharmacists.

COMPETITIVE LANDSCAPE

  • Herbal/traditional products continues to be dominated by medicated confectionery producers. Medicated confectionery is highly popular amongst Czech consumers and such products are commonly used to help prevent and treat flus, colds, and sore throats. Moreover, medicated confectionery products also benefit from strong distribution and are available in a wide range of different channels. Furthermore, leading medicated confectionery brands are also well-known amongst Czech consumers due to strong promotional support from producers.

PROSPECTS

  • Herbal/traditional products constant retail value sales are projected to increase by a healthy 11% over the forecast period, with sales expected to reach CZK1 billion by 2015. Forecast period growth will be higher than that recorded over the review period due to the increasing popularity of herbal products. Health and wellness trends and an increasing focus on self-medication and prevention will be the main drivers of sales of herbal/traditional products over the forecast period.

CATEGORY DATA

  • Table 59 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 60 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 61 Herbal/Traditional Products Company Shares 2006-2010
  • Table 62 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 63 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 64 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in the Czech Republic - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care recorded a relatively healthy current retail value CAGR of 3% over the review period. Consumption of medicated skin care is being fuelled by the fact that the increasingly hectic pace of modern life and worsening environment is resulting in a growing incidence of skin ailments such as allergies, acne, and haemorrhoids. Furthermore, medicated skin care sales are also being fuelled by rising concerns over physical appearance.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bayer led medicated skin care in 2010, recording a retail value share of 10%, and was very closely followed by Novartis. Zentiva ranked third with a retail value share of 9%.

PROSPECTS

  • Medicated skin care constant retail value sales are expected to increase relatively steadily at an average annual rate of 2% over the forecast period to reach CZK1 billion by 2015. Growth over the coming years will be fuelled by the worsening environment, the increasingly hectic pace of modern life, and bad eating habits.

CATEGORY DATA

  • Table 65 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 66 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 67 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 68 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 69 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 70 Acne Treatments Brand Shares by Value 2007-2010
  • Table 71 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 72 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 73 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in the Czech Republic - Category Analysis

HEADLINES

TRENDS

  • NRT smoking cessation aids recorded good current retail value growth of 2% in 2010. Although products in this area are relatively expensive, quitting smoking is an excellent way of reducing household expenditure. However, growth in 2010 was lower than the review period average due to the impact of declining consumer disposable incomes as a result of the economic downturn.

SWITCHES

COMPETITIVE LANDSCAPE

  • NRT smoking cessation aids remains a niche area, with only two multinational players offering such products in 2010. The products of both producers are very similar with regard to format, flavour, and packaging.

PROSPECTS

  • NRT smoking cessation aids constant retail value sales are projected to increase by a total of 7% over the forecast period and to reach CZK95 million by 2015, with demand being fuelled by rising consumer health awareness and the fact that the number of Czechs looking to quit smoking is expected to increase.

CATEGORY INDICATORS

  • Table 74 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 75 Sales of NRT Smoking Cessation Aids by Category: Value 2005-2010
  • Table 76 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2005-2010
  • Table 77 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 78 NRT Smoking Cessation Aids Company Shares by Value 2006-2010
  • Table 79 NRT Smoking Cessation Aids Brand Shares by Value 2007-2010
  • Table 80 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 81 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

OTC Triptans in the Czech Republic - Category Analysis

TRENDS

  • OTC triptans are currently only available via prescription in the Czech Republic and there are no indications that such products will be made available OTC in the foreseeable future.

Sports Nutrition in the Czech Republic - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition remains a relatively small area, recording current retail value sales of just CZK140 million in 2010. Sports nutrition products are mainly purchased by a small number of consumers who are active in sport or regularly go to the gym. Consumption in this area is being driven by rising consumer health and image awareness.

COMPETITIVE LANDSCAPE

  • Sports nutrition is dominated by three players that recorded a combined retail value share of 86% in 2010. Walmark led sales, recording a retail value share of 36%, and was followed by Nutrend DS (26%) and Amway Ceske Republika (24%).

PROSPECTS

  • Sports nutrition constant retail value sales are projected to increase by a healthy 20% over the forecast period and to reach CZK168 million by 2015. However, forecast period growth will be lower than that recorded during the review period due to the impact of the economic downturn on consumer price sensitivity and demand for non-essential products.

CATEGORY DATA

  • Table 82 Sales of Sports Nutrition: Value 2005-2010
  • Table 83 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 84 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 85 Sports Nutrition Company Shares 2006-2010
  • Table 86 Sports Nutrition Brand Shares 2007-2010
  • Table 87 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 88 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015
  • Summary 13 Sports Nutrition, Category Rankings 2010

Vitamins and Dietary Supplements in the Czech Republic - Category Analysis

HEADLINES

TRENDS

  • Vitamins and dietary supplements current retail value growth of 4% in 2010 was slightly higher than the review period average of 3%, with demand being fuelled by rising consumer health awareness and increasing interest in preventative medicine and self-care.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Walmark remained the clear leader within vitamins and dietary supplements in 2010, recording a retail value share of 39%. The company led sales within most main areas, including child-specific vitamins and dietary supplements, dietary supplements (both herbal/traditional and non-herbal/traditional), and vitamins (both multivitamins and single vitamins). In addition, Walmark is very well-known amongst Czech consumers and its products enjoy strong consumer trust in terms of both quality and safety. Moreover, Walmark’s product portfolio is very wide and is constantly being broadened by new and improved products.

PROSPECTS

  • Vitamins and dietary supplements constant retail value sales are projected to increase by a total of 11% over the forecast period. This projected growth is higher than that recorded over the review period, with sales expected to be fuelled by rising consumer health awareness and the fact that a growing number of people are suffering health problems such as obesity, high cholesterol, and diabetes.

CATEGORY DATA

  • Table 89 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 90 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 91 Dietary Supplements by Positioning 2005-2010
  • Table 92 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 93 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 94 Vitamins Brand Shares by Value 2007-2010
  • Table 95 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 96 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 97 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015
  • Summary 14 Dietary Supplements: Brand Ranking by Positioning 2010

Weight Management in the Czech Republic - Category Analysis

HEADLINES

TRENDS

  • Weight management records slight current retail value growth of 1% in 2010, with sales reaching CZK431 million. This relatively low growth can be attributed to the impact of the financial crisis on consumer disposable incomes and a consequent reduction in expenditure in non-essential areas like weight management products.

COMPETITIVE LANDSCAPE

  • Herbalife Czech Republic led weight management sales in 2010, recording a retail value share of 28%. The company led sales within meal replacement slimming, where it recorded a retail value share of 49%, and weight loss supplements, where it recorded a retail value share of 24%. The fact that Herbalife Czech Republic’s Herbalife ShapeWorks brand has been available in the country for a relatively long time means that it is well-known amongst consumers.

PROSPECTS

  • Over the forecast period, weight management sales will be fuelled by the increasing number of overweight and obese people in the Czech Republic. In addition, the fact that a growing number of female consumers desire to comply with conventional ideas of beauty will also drive sales. Furthermore, rising living standards and disposable incomes will also help to boost demand for weight management products.

CATEGORY DATA

  • Table 98 Sales of Weight Management: Value 2005-2010
  • Table 99 Sales of Weight Management: % Value Growth 2005-2010
  • Table 100 Weight Management Company Shares 2006-2010
  • Table 101 Weight Management Brand Shares 2007-2010
  • Table 102 Forecast Sales of Weight Management: Value 2010-2015
  • Table 103 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in the Czech Republic - Category Analysis

HEADLINES

TRENDS

  • A growing number of specialised products such as those that are designed for scars, blisters, or stings or for use on different parts of the body (eg fingers) are being introduced within wound products. Products that reduce fever or relieve pain are mainly intended for children whilst the range of bandage products includes sterile bandages as well as products impregnated with antiseptic ointment.

COMPETITIVE LANDSCAPE

  • Hartmann-Rico was the clear leader within wound care in 2010, recording a retail value share of 40%. The company led sales within all three wound care areas in 2010 and offers a wide range of products that are well known amongst Czech consumers. In addition, the fact that the company also has a very strong distribution network means that its products are easily available throughout the country. Hartman-Rico was established in 1991 and is part of the international group Hartmann and the company has four production plants in the Czech Republic.

PROSPECTS

  • Wound care constant retail value sales are projected to decline by a total of 15% over the forecast period and to fall to CZK340 million by 2015. This fall in sales will be due to declining demand for first aid kits as a result of the fact that the vast majority of motorists have now upgraded their kits in-line with new Ministry of Transport regulations. However, it should be noted that whilst sales are expected to decline dramatically in 2011, they will increase gradually from 2012 onwards.

CATEGORY DATA

  • Table 104 Sales of Wound Care by Category: Value 2005-2010
  • Table 105 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 106 Wound Care Company Shares by Value 2006-2010
  • Table 107 Wound Care Brand Shares by Value 2007-2010
  • Table 108 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 109 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Aloe
            • Guarana
            • Isoflavones
            • Pumpkin Seed
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • L-Carnitine
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Child-Specific Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Child-Specific Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Child-Specific Consumer Health
      • Child-Specific Analgesics
        • Child-Specific Acetaminophen
        • Child-Specific Aspirin
        • Child-Specific Combination Products - Analgesics
        • Child-Specific Diclofenac
        • Child-Specific Dipyrone
        • Child-Specific Ibuprofen
        • Child-Specific Ketoprofen
        • Child-Specific Naproxen
      • Child-Specific Cough, Cold and Allergy Remedies
        • Child-Specific Allergy Remedies
        • Child-Specific Cough/Cold Remedies
      • Child-Specific Digestive Remedies
        • Child-Specific Diarrhoeal Remedies
        • Child-Specific Indigestion and Heartburn Remedies
        • Child-Specific Laxatives
        • Child-Specific Motion Sickness Remedies
      • Child-Specific Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Child-Specific Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

RELATED

Consumer Lifestyle

Future Demographic

Country Report